AbstractThe contest between the host factor APOBEC3G (A3G) and the HIV-1 protein Vif presents an attractive target of intervention. The extent to which the A3G–Vif interaction must be suppressed to tilt the balance in favor of A3G remains unknown. We employed stochastic simulations and mathematical modeling of the within-host dynamics and evolution of HIV-1 to estimate the fraction of progeny virions that must incorporate A3G to render productive infection unsustainable. Using three different approaches, we found consistently that a transition from sustained infection to suppression of productive infection occurred when the latter fraction exceeded ~0.8. The transition was triggered by A3G-induced hypermutations that led to premature stop c...
APOBEC3G (A3G), a deoxycytidine deaminase, is a potent host antiviral factor that can restrict HIV-1...
AbstractHIV-1 Vif inhibits the antiviral activity of APOBEC3G (APO3G) by inducing proteasomal degrad...
BACKGROUND: Naturally occurring Vif variants that are unable to inhibit the host restriction factor ...
The contest between the host factor APOBEC3G (A3G) and the HIV-1 protein Vif presents an attractive ...
AbstractThe contest between the host factor APOBEC3G (A3G) and the HIV-1 protein Vif presents an att...
AbstractA host cytidine deaminase, APOBEC3G (A3G), inhibits replication of human immunodeficiency vi...
Human immunodeficiency virus-1 (HIV-1) employs accessory proteins to evade innate immune responses b...
Humans encode seven APOBEC3 proteins (A–H), with A3G, 3F and 3H as the major factors restricting HIV...
Background: the human APOBEC3G (A3G) protein activity is associated with innate immunity against HIV...
SummaryHuman cells express natural antiviral proteins, such as APOBEC3G (A3G), that potently restric...
The host restriction factor Apobec3G is a cytidine deaminase that incorporates into HIV-1 virions an...
AbstractHIV-1 Vif regulates viral infectivity by inhibiting the encapsidation of APOBEC3G (APO3G) th...
AbstractThe HIV-1 accessory protein Vif (virion infectivity factor) is required for the production o...
AbstractAPOBEC3G (A3G) and APOBEC3F (A3F) reduce Vif-negative HIV-1 provirus formation and cause dis...
The binding of HIV-1 Vif to the cellular cytidine deaminase Apobec3G and subsequent prevention of Ap...
APOBEC3G (A3G), a deoxycytidine deaminase, is a potent host antiviral factor that can restrict HIV-1...
AbstractHIV-1 Vif inhibits the antiviral activity of APOBEC3G (APO3G) by inducing proteasomal degrad...
BACKGROUND: Naturally occurring Vif variants that are unable to inhibit the host restriction factor ...
The contest between the host factor APOBEC3G (A3G) and the HIV-1 protein Vif presents an attractive ...
AbstractThe contest between the host factor APOBEC3G (A3G) and the HIV-1 protein Vif presents an att...
AbstractA host cytidine deaminase, APOBEC3G (A3G), inhibits replication of human immunodeficiency vi...
Human immunodeficiency virus-1 (HIV-1) employs accessory proteins to evade innate immune responses b...
Humans encode seven APOBEC3 proteins (A–H), with A3G, 3F and 3H as the major factors restricting HIV...
Background: the human APOBEC3G (A3G) protein activity is associated with innate immunity against HIV...
SummaryHuman cells express natural antiviral proteins, such as APOBEC3G (A3G), that potently restric...
The host restriction factor Apobec3G is a cytidine deaminase that incorporates into HIV-1 virions an...
AbstractHIV-1 Vif regulates viral infectivity by inhibiting the encapsidation of APOBEC3G (APO3G) th...
AbstractThe HIV-1 accessory protein Vif (virion infectivity factor) is required for the production o...
AbstractAPOBEC3G (A3G) and APOBEC3F (A3F) reduce Vif-negative HIV-1 provirus formation and cause dis...
The binding of HIV-1 Vif to the cellular cytidine deaminase Apobec3G and subsequent prevention of Ap...
APOBEC3G (A3G), a deoxycytidine deaminase, is a potent host antiviral factor that can restrict HIV-1...
AbstractHIV-1 Vif inhibits the antiviral activity of APOBEC3G (APO3G) by inducing proteasomal degrad...
BACKGROUND: Naturally occurring Vif variants that are unable to inhibit the host restriction factor ...